Alembic Ltd
Alembic Limited is engaged in the businesses of Pharmaceuticals, Real Estate, and Power Assets. The company was started in 1907 as the flagship company of the Alembic Group. In 2010, the company demerged its core pharmaceutical business (formulations) into a wholly-owned subsidiary, Alembic Pharma Ltd and after the demerger, APL became the flagship company of the Alembic Group.
With its registered office in Vadodra, Alembic Ltd currently holds a 28.41% stake in Alembic Pharma Ltd and a 19.01% stake in another group entity Paushak Limited.[1]
- Market Cap ₹ 3,031 Cr.
- Current Price ₹ 118
- High / Low ₹ 169 / 85.5
- Stock P/E 9.80
- Book Value ₹ 91.1
- Dividend Yield 2.03 %
- ROCE 6.90 %
- ROE 13.7 %
- Face Value ₹ 2.00
Pros
- Company is almost debt free.
- Company is expected to give good quarter
- Company has been maintaining a healthy dividend payout of 24.1%
- Company's working capital requirements have reduced from 87.5 days to 63.7 days
Cons
- Tax rate seems low
- Company has a low return on equity of 11.6% over last 3 years.
- Earnings include an other income of Rs.74.9 Cr.
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Consumer Discretionary Realty Realty Residential, Commercial Projects
Quarterly Results
Consolidated Figures in Rs. Crores / View Standalone
Profit & Loss
Consolidated Figures in Rs. Crores / View Standalone
Mar 2010 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
1,121 | 144 | 134 | 147 | 125 | 124 | 74 | 74 | 78 | 127 | 157 | 222 | |
1,018 | 134 | 128 | 140 | 114 | 106 | 71 | 62 | 64 | 87 | 101 | 128 | |
Operating Profit | 103 | 10 | 6 | 7 | 11 | 18 | 3 | 11 | 14 | 40 | 57 | 94 |
OPM % | 9% | 7% | 5% | 5% | 9% | 15% | 4% | 15% | 18% | 32% | 36% | 42% |
16 | 21 | 25 | 25 | 37 | 29 | 93 | 10 | 89 | 54 | 55 | 75 | |
Interest | 32 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 2 |
Depreciation | 43 | 6 | 6 | 5 | 4 | 3 | 3 | 4 | 5 | 7 | 8 | 11 |
Profit before tax | 44 | 23 | 25 | 27 | 44 | 45 | 93 | 17 | 98 | 87 | 103 | 156 |
Tax % | 10% | -3% | 2% | -3% | 5% | 8% | 0% | 19% | 12% | 7% | 10% | 7% |
40 | 107 | 235 | 145 | 163 | 213 | 329 | 343 | 222 | 191 | 269 | 311 | |
EPS in Rs | 1.48 | 3.99 | 8.78 | 5.45 | 6.10 | 8.30 | 12.82 | 13.35 | 8.65 | 7.42 | 10.46 | 12.10 |
Dividend Payout % | 17% | 4% | 2% | 4% | 3% | 2% | 5% | 2% | 21% | 30% | 23% | 20% |
Compounded Sales Growth | |
---|---|
10 Years: | 4% |
5 Years: | 25% |
3 Years: | 42% |
TTM: | 41% |
Compounded Profit Growth | |
---|---|
10 Years: | 11% |
5 Years: | -1% |
3 Years: | 12% |
TTM: | 16% |
Stock Price CAGR | |
---|---|
10 Years: | 12% |
5 Years: | 8% |
3 Years: | 18% |
1 Year: | -14% |
Return on Equity | |
---|---|
10 Years: | 15% |
5 Years: | 12% |
3 Years: | 12% |
Last Year: | 14% |
Balance Sheet
Consolidated Figures in Rs. Crores / View Standalone
Mar 2010 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Equity Capital | 27 | 53 | 53 | 53 | 53 | 51 | 51 | 51 | 51 | 51 | 51 | 51 |
Reserves | 311 | 474 | 750 | 858 | 1,032 | 1,157 | 1,367 | 2,246 | 2,445 | 2,027 | 2,134 | 2,287 |
408 | 0 | 9 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 9 | 14 | |
251 | 91 | 64 | 81 | 73 | 57 | 53 | 112 | 135 | 127 | 134 | 150 | |
Total Liabilities | 997 | 619 | 875 | 992 | 1,159 | 1,266 | 1,471 | 2,409 | 2,632 | 2,205 | 2,329 | 2,503 |
393 | 169 | 146 | 171 | 179 | 209 | 225 | 265 | 297 | 321 | 369 | 409 | |
CWIP | 4 | 2 | 0 | 0 | 0 | 0 | 3 | 6 | 0 | 0 | 1 | 0 |
Investments | 8 | 299 | 605 | 732 | 913 | 1,001 | 1,133 | 2,047 | 2,208 | 1,754 | 1,786 | 1,900 |
591 | 149 | 124 | 89 | 67 | 55 | 110 | 91 | 127 | 130 | 173 | 194 | |
Total Assets | 997 | 619 | 875 | 992 | 1,159 | 1,266 | 1,471 | 2,409 | 2,632 | 2,205 | 2,329 | 2,503 |
Cash Flows
Consolidated Figures in Rs. Crores / View Standalone
Mar 2010 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
149 | 22 | 10 | 52 | 24 | 22 | 7 | -2 | -18 | 39 | 23 | 86 | |
-24 | 5 | -5 | -47 | -22 | 68 | 57 | -35 | 19 | 7 | 26 | -27 | |
-118 | -25 | -5 | -5 | -3 | -89 | -6 | -15 | -6 | -46 | -48 | -58 | |
Net Cash Flow | 7 | 2 | -0 | -0 | -1 | 1 | 57 | -52 | -5 | -0 | 0 | 1 |
Ratios
Consolidated Figures in Rs. Crores / View Standalone
Mar 2010 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Debtor Days | 63 | 122 | 76 | 54 | 74 | 40 | 44 | 69 | 71 | 67 | 46 | 49 |
Inventory Days | 158 | 880 | 659 | 438 | 247 | 289 | 411 | 2,112 | 2,885 | 3,694 | ||
Days Payable | 128 | 200 | 144 | 128 | 125 | 202 | 151 | 693 | 640 | 1,237 | ||
Cash Conversion Cycle | 93 | 801 | 591 | 364 | 195 | 126 | 305 | 1,488 | 2,316 | 67 | 2,502 | 49 |
Working Capital Days | 108 | 235 | 172 | 39 | 20 | 13 | 22 | 98 | 223 | 118 | 81 | 64 |
ROCE % | 10% | 4% | 4% | 4% | 4% | 7% | 1% | 4% | 4% | 5% | 7% |
Documents
Announcements
-
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
7 Jul - Certificate under regulation 74(5) of the SEBI (Depositories & Participants) Regulations, 2018 for the quarter ended 30th June, 2025, received from M/s. MUFG Intime India …
-
Intimation Under Regulation 30 Of SEBI (LODR) Regulation, 2015
7 Jul - Notice of 118th AGM on 12 Aug 2025 and Annual Report FY 2024-25 access details provided.
-
Announcement under Regulation 30 (LODR)-Newspaper Publication
5 Jul - Copy of the notice published in Indian Express (English edition) and Financial Express (Gujarati edition - vernacular language) on 5th July, 2025 inter alia informing …
- Intimation Of Record Date For Payment Of Dividend On Equity Shares For The Financial Year Ended 31St March, 2025 4 Jul
-
Business Responsibility and Sustainability Reporting (BRSR)
4 Jul - Alembic Limited submits FY25 Business Responsibility & Sustainability Report as per SEBI regulations.
Annual reports
-
Financial Year 2025
from bse
-
Financial Year 2024
from bse
-
Financial Year 2023
from bse
-
Financial Year 2022
from bse
-
Financial Year 2021
from bse
-
Financial Year 2020
from bse
-
Financial Year 2019
from bse
-
Financial Year 2018
from bse
-
Financial Year 2017
from bse
-
Financial Year 2016
from bse
-
Financial Year 2015
from bse
-
Financial Year 2014
from bse
-
Financial Year 2013
from bse
-
Financial Year 2012
from bse
-
Financial Year 2011
from nse
Business Segments
A) Real Estate (~80% in FY24 vs 59% in FY22): [1] [2] The company is involved in the construction of residential & commercial real estate projects. It also leases commercial properties. [3] Real Estate business experienced strong growth between FY23-FY24 bolstered by strong demand and higher property prices. [4]